Effexor and Moviprep drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Effexor (venlafaxine hydrochloride) and Moviprep (ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate). Common drug interactions include deep vein thrombosis among females and general physical health deterioration among males.
The phase IV clinical study analyzes what interactions people have when they take Effexor and Moviprep. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.
What is Effexor?
Effexor has active ingredients of venlafaxine hydrochloride. It is often used in depression. eHealthMe is studying from 99,493 Effexor users. Check the latest studies of Effexor.
What is Moviprep?
Moviprep has active ingredients of ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate. It is often used in colonoscopy abnormal. eHealthMe is studying from 3,173 Moviprep users. Check the latest studies of Moviprep.
26 people who take Effexor and Moviprep together, and have interactions are studied.

What are the common drug interactions of Effexor and Moviprep, by gender? *:
female:
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Dyspnoea (difficult or laboured respiration)
- Gastrointestinal obstruction
- Weight decreased
- Alopecia (absence of hair from areas of the body)
- Anaemia (lack of blood)
- Dizziness
- Dysgeusia (disorder of the sense of taste)
- Hair colour changes
- Hair disorder
male:
- General physical health deterioration (weak health status)
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
- Eye movement disorder
- Fatigue (feeling of tiredness)
- Headache (pain in head)
- Hemiparesis (weakness on one side of the body)
- Injury
- Loss of consciousness
- Malaise (a feeling of general discomfort or uneasiness)
- Nausea (feeling of having an urge to vomit)
What are the common drug interactions of Effexor and Moviprep, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Chronic kidney disease
- Coma (state of unconsciousness lasting more than six hours)
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Lung disorder (lung disease)
- Nephrogenic anaemia (anaemia due to kidney disease)
- Renal failure (kidney dysfunction)
- Renal failure acute (rapid kidney dysfunction)
- Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
50-59:
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Gastrointestinal obstruction
- Anaemia (lack of blood)
- Dyspnoea (difficult or laboured respiration)
- Ileus (a painful obstruction of the ileum or other part of the intestine)
- Pneumonitis (inflammation of the walls of the alveoli in the lungs)
- Burning sensation
- Cough
- Dizziness
- Face oedema (swelling of face)
60+:
- General physical health deterioration (weak health status)
- Asthenia (weakness)
- Eye movement disorder
- Fatigue (feeling of tiredness)
- Headache (pain in head)
- Hemiparesis (weakness on one side of the body)
- Injury
- Loss of consciousness
- Malaise (a feeling of general discomfort or uneasiness)
- Nausea (feeling of having an urge to vomit)
What are the existing conditions these people have? *
- Pain: 11 people, 42.31%
- High Blood Pressure: 7 people, 26.92%
- Ill-Defined Disorder: 5 people, 19.23%
- Hot Flush (sudden feelings of heat): 5 people, 19.23%
- Constipation: 5 people, 19.23%
- Nausea (feeling of having an urge to vomit): 5 people, 19.23%
- Asthma: 4 people, 15.38%
- Stress And Anxiety: 3 people, 11.54%
- Indigestion: 2 people, 7.69%
- Insomnia (sleeplessness): 2 people, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Effexor and Moviprep?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Effexor and Moviprep:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Effexor:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Moviprep:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Effexor and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Moviprep and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on venlafaxine hydrochloride and ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate (the active ingredients of Effexor and Moviprep, respectively), and Effexor and Moviprep (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- How effective is Lithane for Bipolar Ii Disorder? - 13 seconds ago
- Could Stelara cause Haematemesis? - 17 seconds ago
- Could Carboplatin cause Hepatitis C? - 21 seconds ago
- Drug interactions of Austedo and Tetrabenazine - 27 seconds ago
- Could Diclofenac Potassium cause General Physical Health Deterioration? - 33 seconds ago
- Could Tylenol cause Histiocytosis Haematophagic? - 39 seconds ago
- Could Akineton cause Mood Swings? - 44 seconds ago
- Drug interactions of Xolair and Azathioprine - 47 seconds ago
- Drug interactions of Motrin and Robinul - 59 seconds ago
- Drug interactions of Januvia and Cefazolin Sodium - a minute ago